Walvax Biotechnology Co., Ltd. (SHE:300142)

Walvax Biotechnology Revenue

Walvax Biotechnology had revenue of 564.60M CNY in the quarter ending September 30, 2025, a decrease of -20.25%. This brings the company's revenue in the last twelve months to 2.40B, down -22.54% year-over-year. In the year 2024, Walvax Biotechnology had annual revenue of 2.82B, down -31.41%.

• Revenue (ttm): 2.40B
• Revenue Growth: -22.54%
• P/S Ratio: 8.15
• Revenue / Employee: 1.00M
• Employees: 2,388
• Market Cap: 19.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.82B	-1.29B	-31.41%
Dec 31, 2023	4.11B	-972.67M	-19.12%
Jan 1, 2023	5.09B	1.62B	46.89%
Jan 1, 2022	3.46B	523.81M	17.82%
Dec 31, 2020	2.94B	1.82B	162.13%